Compound preparation containing lutein ester and preparation method thereof

A technology of compound preparation and lutein ester, applied in the field of prevention or treatment of age-related macular degeneration and relief of visual fatigue, compound preparation containing lutein ester and its preparation, can solve the problem of low bioavailability and high processing cost , poor stability and other issues, to achieve high bioavailability, prevent damage, and protect the retina

Active Publication Date: 2014-04-23
ZHEJIANG UNIV OF TECH
View PDF2 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This technical scheme adopts lutein etc. as the main functional substances, and its disadva

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound preparation containing lutein ester and preparation method thereof
  • Compound preparation containing lutein ester and preparation method thereof
  • Compound preparation containing lutein ester and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0060] Example 1: Lutein ester capsules containing lycopene, wolfberry extract and cassia seed powder

[0061] Prescription (based on 200mg total component content of each drug):

[0062]

[0063]

[0064] Preparation:

[0065] The above prescription amount of lutein ester, lycopene, wolfberry extract, zinc gluconate, vitamin C and starch are fed in 10,000 times the amount, and they are passed through an 80-mesh sieve to obtain fine powder, which is then mixed with cassia seed powder. , Adding starch slurry to make soft material, granulating, drying in an oven at 60°C; adding magnesium stearate (magnesium stearate has been pre-passed through an 80-mesh sieve), mixing uniformly, sizing, and filling into capsules.

Example Embodiment

[0066] Example 2: Lutein ester capsules containing lycopene, wolfberry extract and cassia powder

[0067] Prescription (based on 200mg total component content of each drug):

[0068]

[0069] Preparation:

[0070] In this example, sucrose was used as diluent, low-substituted hydroxypropyl cellulose was used as disintegrant, talc was used as glidant, and water was used as binder. Each component of the prescription was passed through a 100-mesh sieve and granulated at 70°C. Dry in an oven, and the other preparation methods are the same as in Example 1.

Example Embodiment

[0071] Example 3: Lutein ester capsules containing lycopene, wolfberry extract and cassia seed powder

[0072] Prescription (based on 200mg total component content of each drug):

[0073]

[0074] Preparation:

[0075] In this example, glucose was used as diluent, sodium carboxymethyl starch was used as disintegrant, sodium lauryl sulfate was used as glidant, and ethanol was used as binder. Each component of the prescription was passed through an 80-mesh sieve. Dry in an oven at 50°C, and the other preparation methods are the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention provides a compound preparation containing lutein ester, which is taken orally. The compound preparation comprises the following raw materials in parts by weight: 0.3-10.1 parts of lutein, 0-12.2 parts of lycopene, 0.1-18.7 parts of beta-carotene, 0-6.3 parts of vitamin B1, 0-7.2 parts of vitamin B2, 12.6-33.8 parts of vitamin C, 0-10.6 parts of vitamin E, 18.15-42.75 parts of zinc gluconate, 0-126.6 parts of wolfberry extract and 0-89.5 parts of cassia seed powder. The compound preparation containing lutein ester provided by the invention is scientific and reasonable in prescription composition and content collocation, innovative and feasible in process, and both capable of reducing the raw material cost, and greatly improving the bioavailability and biological safety for taking, generating synergistic interaction, significantly preventing and treating AMD disease and helping to alleviate visual fatigue, so that the market application prospect is wide.

Description

technical field [0001] The invention belongs to the technical field of medical and health products, and relates to a compound preparation containing lutein ester and a preparation method thereof, which are mainly used in preventing or treating age-related macular degeneration and relieving visual fatigue. Background technique [0002] Eyes are an important organ for people to acquire knowledge, and they are also sensitive organs that are prone to damage. Excessive use of eyes, myopia, hyperopia, astigmatism and neurasthenia will all cause visual fatigue. Visual fatigue will increase the incidence of various eye diseases, such as age-related Macular degeneration, retinal detachment, etc., can lead to blindness in severe cases. [0003] Among them, age-related macular degeneration (age-related macular degeneration, referred to as AMD, also known as age-related macular degeneration), is divided into two types: dry and wet, and is considered to be one of the most difficult eye d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/815A61P27/02A61K31/525A61K31/51A61K31/375A61K31/355A61K31/025A61K31/01A61K31/191
Inventor 马凤森周密方多凤
Owner ZHEJIANG UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap